← Evidence map

ReviewAutoimmunity reviews2014

Interleukin-22: a likely target for treatment of autoimmune diseases.

Xuyan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

50 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24418299